Skip to main content

Table 2 The baseline characteristics of study subjects categorized by central obesity

From: Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study

 

With central obesity

Without central obesity

P

No. of patients

234

361

 

Male gender, n (%)

105 (44.9%)

169 (46.8%)

0.755

Age (years)

50.0±9.4

46.9±8.0

<0.001

Smoking (packs/day)

6.4±11.8

3.6±8.5

<0.001

Waist circumference (cm)

91.9±7.3

77.4±7.0

<0.001

Systolic BP (mmHg)

135±25

123±25

<0.001

Diastolic BP (mmHg)

79±14

75±14

<0.001

Fasting glucose (mmol/L)

5.1±0.6

4.9±0.5

<0.001

Triglyceride (mmol/L)

1.5±0.8

1.3±0.8

<0.001

HDL cholesterol (mmol/L)

1.1±0.3

1.2±0.3

<0.001

HOMA-IR

2.1±1.3

1.3±0.9

<0.001

Incidence of diabetes (per 1000person-years)

55.7

30.0

0.009

  1. Abbreviations: BP= blood pressure, HDL= high-density lipoprotein, HOMA-IR= homeostasis model assessment for insulin resistance.